Thromboprophylaxis for Intensive Care Patients

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 1

Abstract

The advent of low-molecular-weight heparin (LMWH) marked a new chapter in the prevention of venous thromboembolism. The enviable pharmacokinetic properties associated with this class of medication, ensured the place of LMWH as an attractive, if albeit more expensive alternative to unfractionated heparin. Predictable and reproducible dose response continues to negate the need for monitoring in most patient groups, while the availability of antidotes further boosts the safety profile of LMWH. These agents have long proven their worth in the medico-surgical patient population. However we have recently shown in randomised studies, that LMWH at the current recommended dose may not be as effective for critically ill patients. Critically ill patients encompass that population of patients with profound disturbance of physiology, who are at imminent risk of death and in need of continuous care. Such patients have proven to be somewhat resistant, and current evidence indicates that they may benefit from a higher dose of LMWH. A difficult undertaking, considering the heterogeneity of this population, as well as their predisposition to both haemorrhage and thromboembolism. A variety of new oral antithrombotics has recently become available for use among certain patient populations, but has not yet been studied in the intensive care unit (ICU) setting. These agents have been associated with increased risk of bleeding, and as yet, a definitive strategy in the event of major bleeding does not exist. In addition, they are more costly when compared with LMWH. All the aforementioned factors combine to make the new oral agents, unattractive alternatives for thromboprophylaxis in the ICU population.

Authors and Affiliations

Sian Robinson, Palle Toft

Keywords

Related Articles

Activity of Autonomic Nervous System, Energy Expenditure and Assessment of Oxidative Stress in Menopause-women Using Hormone Replacement Therapy

Aims: Menopause is a period of significant physiological change that may be associated with increased body weight and obesity-related diseases. Many studies have been carried out to determine influences of estrogen deple...

Writing on One’s Own Demise: Suicide Notes in the Age of the Internet

One to two people out of six who attempt suicide will leave a note behind. In comparison to notes written on paper, internet suicide notes may differ in a variety of characteristics, as they illustrate different degrees...

Short Term Rehospitalisation or Death and Determinants after Acute Heart Failure Admission in a Cohort of African Patients in Port Harcourt, Southern Nigeria

Background: Heart failure [HF] is a major health burden globally and contributes significantly to morbidity and mortality related to cardiovascular disease. The aim was to determine the outcome and factors that determine...

Prediction of Renal Injury Risk by Expressions of KIM-1 and NGAL in Type 2 Diabetic Nephropathy

Background: About 10 to 40% Type 2 diabetes (T2DM) and 30% Type 1 diabetes (T1DM) suffer from kidney failure increases huge financial burden for care for patients [1]. Patients with uncontrolled diabetes prone to end-sta...

Reflective Learning Experience in Primary Care Medicine Posting: A Potential Qualitative Study

Purpose: The purpose of this study is to determine the effects of reflection on learning during family medicine posting, to introduce a reflective writing exercise into an undergraduate medical curriculum, including thei...

Download PDF file
  • EP ID EP348463
  • DOI 10.9734/BJMMR/2014/5553
  • Views 89
  • Downloads 0

How To Cite

Sian Robinson, Palle Toft (2014). Thromboprophylaxis for Intensive Care Patients. Journal of Advances in Medicine and Medical Research, 4(1), 46-56. https://europub.co.uk/articles/-A-348463